DIOTALLEVI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 1.815
EU - Europa 561
AS - Asia 245
AF - Africa 67
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.692
Nazione #
US - Stati Uniti d'America 1.806
SE - Svezia 134
IE - Irlanda 132
IT - Italia 132
CN - Cina 131
SG - Singapore 79
CI - Costa d'Avorio 42
FR - Francia 36
UA - Ucraina 33
GB - Regno Unito 30
IN - India 25
MA - Marocco 25
DE - Germania 24
FI - Finlandia 11
BE - Belgio 9
GR - Grecia 6
CA - Canada 5
JP - Giappone 5
CU - Cuba 4
DK - Danimarca 4
KR - Corea 4
RU - Federazione Russa 4
AU - Australia 3
CZ - Repubblica Ceca 2
ES - Italia 2
AT - Austria 1
CH - Svizzera 1
EU - Europa 1
HK - Hong Kong 1
Totale 2.692
Città #
Chandler 385
Des Moines 248
Ashburn 141
Dublin 125
Boardman 119
New York 104
Fairfield 88
Jacksonville 56
Lawrence 46
Princeton 46
Woodbridge 45
Abidjan 42
Wilmington 40
Seattle 34
Cambridge 27
San Mateo 27
Houston 26
Singapore 23
Centro 21
Guangzhou 20
Pune 20
Turin 18
Ann Arbor 17
Los Angeles 17
San Diego 17
Washington 16
London 14
Ancona 12
Redmond 11
Dallas 10
Boydton 9
Brussels 9
Helsinki 9
Shanghai 8
Beijing 7
Wuhan 7
Cagliari 6
Norwalk 6
Toronto 5
Civitanova Marche 4
Havana 4
Polverigi 4
San Vito Chietino 4
Clifton 3
Falerone 3
Hounslow 3
Kingston 3
Rome 3
Shenzhen 3
Sydney 3
Tokyo 3
Wuxi 3
Ascoli Piceno 2
Cernusco sul Naviglio 2
Frankfurt am Main 2
Ginosa 2
Guwahati 2
Hangzhou 2
Heze 2
Jiaxing 2
Kilburn 2
Moscow 2
Naples 2
New Bedfont 2
Norrköping 2
Parma 2
Prescot 2
Quanzhou 2
Redwood City 2
Rimini 2
Valencia 2
Yiwu 2
Zibo 2
Aquila 1
Campagnano di Roma 1
Caserta 1
Castelfidardo 1
Central 1
Chengdu 1
Chiaravalle 1
Chicago 1
Dalian 1
Dongyang 1
Duisburg 1
Filottrano 1
Florence 1
Jinhua 1
Laurel 1
Mentana 1
Monsampolo del Tronto 1
Nanjing 1
Noginsk 1
Novara 1
Nuremberg 1
Olomouc 1
Pesaro 1
Qingdao 1
Riva 1
Saint Petersburg 1
Santa Clara 1
Totale 1.993
Nome #
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 82
Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate 82
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 74
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 73
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 72
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 70
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 68
Granuloma faciale successfully treated with ingenol mebutate 66
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 65
Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital 64
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 64
Safety update of etanercept treatment for moderate to severe plaque psoriasis 63
Reticulated acanthoma with sebaceous differentiation 63
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 63
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 61
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 59
The efficacy of in vivo administration of Apremilast on mesenchymal stem cells derived from psoriatic patients 59
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 57
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 57
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 56
VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should now 56
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 56
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 54
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 54
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 53
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 53
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis 53
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 50
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 49
Topical application of fumaric acid esters improves appearance of nail psoriasis 47
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 44
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 44
Acral Leukoderma: Is It Always Vitiligo? 43
Asymptomatic pigmentation of the skin in a child: babywipes, once again 42
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 42
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 41
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 39
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 39
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 38
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 38
Saliva and Oral Diseases 37
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 36
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 36
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 32
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 30
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 28
miRNome analysis in psoriatic patients treated with anti IL- 23: a cohort study 27
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 27
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 25
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 23
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 23
Trichorhinophalangeal syndrome: a case report and brief literature review. 23
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 20
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study 19
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 19
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 19
Mesenchymal Stem Cells and Psoriasis: Systematic Review 16
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 14
Biological treatments for pediatric psoriasis: state of the art and future perspectives 13
miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review 12
Role of daptomycin in cutaneous wound healing: a narrative review 12
null 12
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 12
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: A multicentre study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 11
The pharmacological treatment and management of hyperhidrosis 8
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 8
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 5
Totale 2.800
Categoria #
all - tutte 20.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 2 6 18 0 8 2 10 9 3 18
2020/2021287 14 21 24 17 22 2 9 19 29 27 73 30
2021/2022368 10 41 3 2 42 21 3 28 28 7 98 85
2022/20231.090 81 112 67 104 61 335 1 51 191 2 56 29
2023/2024650 88 11 59 59 81 179 13 55 4 24 23 54
2024/2025307 155 121 31 0 0 0 0 0 0 0 0 0
Totale 2.800